Orlando, Fla.—Oncology organizations and patient advocacy groups are urging their members to speak out against a newly proposed drug reimbursement plan from the Centers for Medicare & Medicaid Services (CMS) to change Medicare Part B payments.
More than 300 organizations have opposed the initiative, which they say will adversely affect the care and treatment of Medicare patients, including those being treated for cancer.
This proposal shows a “fundamental misunderstanding of the